Who owns AN2 THERAPEUTICS INC?
- Ticker: ANTX
- CUSIP Number: 037326105
Tip: Access positions for across all investors
Analyze quarterly positions in An2 Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of An2 Therapeutics stock
Who bought or sold AN2 THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Almitas Capital | 1.4M | $1.8M | 0% | Sep 2025 |
|
| Vanguard Group | 1.1M | $1.4M | 4% | Sep 2025 |
|
| Pfizer | 715k | $908k | 0% | Sep 2025 |
|
| Peapod Lane Capital | 589k | $748k | 1% | Sep 2025 |
|
| Stonepine Capital Management | 564k | $716k | 4% | Sep 2025 |
|
| Bank of Nova Scotia | 459k | $583k | 0% | Sep 2025 |
|
| Landscape Capital Management | 457k | $580k | -8% | Sep 2025 |
|
| Bank Of Montreal | 422k | $447k | 100% | Jun 2025 |
|
| Renaissance Technologies | 386k | $490k | -3% | Sep 2025 |
|
| BlackRock | 321k | $408k | 1% | Sep 2025 |
|
| Two Sigma Advisers | 268k | $340k | -1% | Sep 2025 |
|
| Geode Capital Management | 249k | $317k | 0% | Sep 2025 |
|
| Two Sigma Investments | 223k | $284k | -6% | Sep 2025 |
|
| Morgan Stanley | 178k | $189k | 100% | Jun 2025 |
|
| State Street Corporation | 87k | $111k | 0% | Sep 2025 |
|
| Rangeley Capital | 65k | $83k | 0% | Sep 2025 |
|
| Squarepoint Ops | 64k | $82k | 539% | Sep 2025 |
|
| Bridgeway Capital Management | 60k | $76k | 0% | Sep 2025 |
|
| UBS Group | 57k | $72k | -9% | Sep 2025 |
|
| Northern Trust | 43k | $55k | 0% | Sep 2025 |
|
| Captrust Financial Advisors | 40k | $51k | 0% | Sep 2025 |
|
| Citadel Advisors | 23k | $29k | 84% | Sep 2025 |
|
| Private Advisor | 23k | $29k | 0% | Sep 2025 |
|
| XTX Topco | 19k | $24k | -29% | Sep 2025 |
|
| Schonfeld Strategic Advisors | 14k | $18k | -17% | Sep 2025 |
|
| ACT Advisors | 13k | $17k | 100% | Sep 2025 |
|
| Federated Investors | 12k | $15k | -3% | Sep 2025 |
|
| Qube Research & Technologies | 10k | $13k | 0% | Sep 2025 |
|
| Highline Wealth Partners | 5.0k | $6.4k | 0% | Sep 2025 |
|
| Tower Research Capital | 2.1k | $2.7k | -60% | Sep 2025 |
|
| FMR | 1.0k | $1.3k | 100% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 303.00 | $384.991800 | -3% | Sep 2025 |
|
| Advisor Group Holdings | 300.00 | $384.000000 | 0% | Sep 2025 |
|
| SBI Securities | 200.00 | $254.000000 | 0% | Sep 2025 |
|
Who sold out of An2 Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Susquehanna International | Jun 2025 | 45k | $48k |
| Integrated Wealth Concepts | Jun 2025 | 25k | $27k |
| Hrt Financial | Jun 2025 | 13k | $13k |